![four separate images in a collage showing students working in labs](http://cdn-acquia.dundee.ac.uk/sites/default/files/styles/card/public/2021-10/Honours%20Project%20Students%20in%20lab%20Oct%202021.jpg?itok=FkbfcBtG)
News
The new academic year 2021/22 has started and the School has welcomed the new intake of Honours project students.
News
The new academic year 2021/22 has started and the School has welcomed the new intake of Honours project students.
Press release
A University of Dundee-led programme that will train the next generation of barley researchers has received a multi-million pound investment.
Press release
A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.
News
The twelve major BSc Honours degree programmes offered by the University of Dundee in Biological and Biomedical Sciences have been awarded accreditation by the Royal Society of Biology for a further five years.
News
This year, the School of Life Sciences student representatives have worked hard to increase engagement, boost employability prospects and raise awareness of student wellbeing.
Press release
A novel vaccine production platform that could prove decisive in the battle against Streptococcus is among the University of Dundee innovations recognised in Scotland’s largest company creation programme for the higher education sector.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
News
Elena Purlyte, lead of the PiCLS committee between May 2018 until September 2019, has looked back on the achievements of the committee during her tenure.
Press release
An entrepreneurial scientist from the University of Dundee has proven his business concept is more than skin deep after winning one of the country’s top enterprise awards
News
Over 50 undergraduate students have been undertaking life science summer projects within the University over the past few months.
News
The Schools of Life Sciences and Medicine are delighted to host eight of our undergraduate students who are undertaking Medical Research Scotland funded vacation scholarships with researchers in the Schools.
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).
Press release
Exscientia, a world leader in artificial intelligence (“AI”) driven drug discovery and a spinout company of the University of Dundee announced today that it has entered a three-year AI drug discovery partnership with leading biopharma company Celgene
Press release
The University of Dundee has recorded one of the highest scores in the latest International Student Barometer (ISB)
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK